HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William E Pullman Selected Research

ecallantide

3/2013Outcomes after ecallantide treatment of laryngeal hereditary angioedema attacks.
3/2013Efficacy and safety of ecallantide in treatment of recurrent attacks of hereditary angioedema: open-label continuation study.
3/2012Ecallantide for treatment of acute hereditary angioedema attacks: analysis of efficacy by patient characteristics.
7/2011Ecallantide (DX-88) for acute hereditary angioedema attacks: integrated analysis of 2 double-blind, phase 3 studies.
12/2010Response time for ecallantide treatment of acute hereditary angioedema attacks.
8/2010Ecallantide for the treatment of acute attacks in hereditary angioedema.
6/2010EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William E Pullman Research Topics

Disease

7Hereditary Angioedemas
03/2013 - 06/2010
2Angioedema
07/2011 - 08/2010
1Epilepsy (Aura)
11/2020
1Seizures (Absence Seizure)
11/2020
1Pain (Aches)
03/2012

Drug/Important Bio-Agent (IBA)

7ecallantideFDA Link
03/2013 - 06/2010
2BradykininIBA
03/2012 - 07/2011
2Plasma KallikreinIBA
07/2011 - 08/2010
1Nasal SpraysIBA
11/2020
1Midazolam (Versed)FDA LinkGeneric
11/2020